← back to search

Maxim Mogilevsky

Hebrew University of Jerusalem · IL
Area of research
Molecular Biology · Genetics
Research interest
Research focused on RNA splicing and Alternative splicing, with related work in Cancer research, Cancer cell, Oligonucleotide. Notable publications include 'Intra-Tumoral Metabolic Zonation and Resultant Phenotypic Diversification Are Dictated by Blood Vessel Proximity', 'Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation', and 'Specific inhibition of splicing factor activity by decoy RNA oligonucleotides'.
h-index
citations
593
works
10
NIH funding
primary concept
email

Recent publications

RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
Nature 2023cited by 88position: middledoi
Identification of vascular cues contributing to cancer cell stemness and function
Angiogenesis 2022cited by 16position: middledoi
Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
Oncogenesis 2020cited by 16position: middledoi
Intra-Tumoral Metabolic Zonation and Resultant Phenotypic Diversification Are Dictated by Blood Vessel Proximity
Cell Metabolism 2019cited by 121position: middledoi
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Nature Communications 2019cited by 100position: middledoi
2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels
Frontiers in Pharmacology 2019cited by 26position: middledoi
Modulation of<i>MKNK2</i>alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
Nucleic Acids Research 2018cited by 70position: firstdoi
CLIP6-PNA-Peptide Conjugates: Non-Endosomal Delivery of Splice Switching Oligonucleotides
Bioconjugate Chemistry 2017cited by 28position: middledoi
RETRACTED: Generalized verrucosis and abnormal T cell activation due to homozygous TAOK2 mutation
Journal of Dermatological Science 2017cited by 12position: middledoi
Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation
Cell Reports 2014cited by 116position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rotem Karni · Hebrew University of Jerusalem9 papers (2014–2023)Saran Kumar · National University of Singapore4 papers (2018–2022)Eylon Yavin · Hebrew University of Jerusalem3 papers (2017–2019)Eli Keshet · Hebrew University of Jerusalem3 papers (2018–2022)Odelia Shimshon · Hebrew University of Jerusalem2 papers (2018–2019)Iddo Paldor · Hebrew University of Jerusalem2 papers (2019–2022)Libat Bar-Lev · Hebrew University of Jerusalem2 papers (2019–2022)Asaf Shilo · Hebrew University of Jerusalem2 papers (2014–2019)Husni Sharife · Hebrew University of Jerusalem2 papers (2019–2022)Myriam Grunewald · Hadassah Medical Center2 papers (2019–2022) · 2 papers (2019–2023)Miri Danan-Gotthold · Weizmann Institute of Science2 papers (2019–2023)Tirzah Kreisel · Hebrew University of Jerusalem1 papers (2019–2019) · 1 papers (2019–2019)Jermaine Goveia · VIB-KU Leuven Center for Cancer Biology1 papers (2022–2022)Gun Ho Jang · Ontario Institute for Cancer Research1 papers (2023–2023)Ahmed Idbaïh · Institut de Myologie1 papers (2020–2020)Shaya Lev · Hebrew University of Jerusalem1 papers (2019–2019)Alik Honigman · Hebrew University of Jerusalem1 papers (2019–2019)Avraham Maimon · Hebrew University of Jerusalem1 papers (2014–2014)